ES2166996T3 - Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios. - Google Patents

Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios.

Info

Publication number
ES2166996T3
ES2166996T3 ES97924591T ES97924591T ES2166996T3 ES 2166996 T3 ES2166996 T3 ES 2166996T3 ES 97924591 T ES97924591 T ES 97924591T ES 97924591 T ES97924591 T ES 97924591T ES 2166996 T3 ES2166996 T3 ES 2166996T3
Authority
ES
Spain
Prior art keywords
compounds
reagent
blood
antiplatelet
antiplaquetary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97924591T
Other languages
English (en)
Inventor
Christopher P Carron
Larry P Feigen
Neal F Haas
Debra M Meyer
Jimmy D Page
Jodi Ann Pegg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2166996T3 publication Critical patent/ES2166996T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/808—Optical sensing apparatus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN PROCEDIMIENTO PARA DETERMINAR LA CANTIDAD DE UN COMPUESTO ANTIPLAQUETARIO EN UN SUJETO QUE ESTA SIENDO TRATADO CON EL COMPUESTO Y QUE CONSISTE EN CALCULAR EL NUMERO DE ACT DE LA SANGRE DEL SUJETO QUE CONTIENE UN REACTIVO QUE INMUNORREACCIONA CON EL COMPUESTO ANTIPLAQUETARIO Y COMPARAR EL NUMERO CON UN NUMERO DE CONCENTRACION NORMALIZADA. EN SUJETOS QUE ESTAN SIENDO TRATADOS AL MISMO TIEMPO CON HEPARINA Y COMPUESTOS ANTIPLAQUETARIOS, EL PROCEDIMIENTO SE PUEDE LLEVAR A CABO SIN AÑADIR MAS HEPARINA A LA MUESTRA DE SANGRE. EN LA INVENCION TAMBIEN SE PRESENTAN REACTIVOS QUE INMUNORREACCIONAN CON LOS COMPUESTOS ANTIPLAQUETARIOS Y KITS QUE CONTIENEN LOS REACTIVOS INMUNORREACTIVOS.
ES97924591T 1996-05-15 1997-05-12 Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios. Expired - Lifetime ES2166996T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1771096P 1996-05-15 1996-05-15

Publications (1)

Publication Number Publication Date
ES2166996T3 true ES2166996T3 (es) 2002-05-01

Family

ID=21784121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97924591T Expired - Lifetime ES2166996T3 (es) 1996-05-15 1997-05-12 Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios.

Country Status (11)

Country Link
US (1) US6150114A (es)
EP (1) EP0912901B1 (es)
JP (1) JP2000510700A (es)
AT (1) ATE208505T1 (es)
AU (1) AU2997597A (es)
CA (1) CA2253402A1 (es)
DE (1) DE69708102T2 (es)
DK (1) DK0912901T3 (es)
ES (1) ES2166996T3 (es)
PT (1) PT912901E (es)
WO (1) WO1997043650A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221672B1 (en) * 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
AU1712700A (en) * 1998-11-18 2000-06-05 G.D. Searle & Co. Restoration of platelet aggregation by antibody administration after gpiib/iiia antagonist treatment
US6972296B2 (en) 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
CZ303312B6 (cs) * 1999-05-07 2012-07-25 Texas Biotechnology Corporation Deriváty karboxylové kyseliny, které inhibují vazbu integrinu na jejich receptory
WO2005111231A2 (en) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393040A (en) * 1981-03-24 1983-07-12 Lopapa Institute, Inc. In-vitro diagnostic method for detection of acetylsalicylic acid ingestion
US4871677A (en) * 1985-02-25 1989-10-03 Hemotec, Inc. Method of collecting and analyzing a sample of blood when monitoring heparin therapy
US5182260A (en) * 1989-01-27 1993-01-26 Biogen, Inc. Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them
US5290680A (en) * 1991-06-28 1994-03-01 Takeda Chemical Industries, Ltd. Monoclonal antibody, method of production thereof and use thereof
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
US5721366A (en) * 1993-03-31 1998-02-24 G. D. Searle & Co Platelet aggregation inhibitors
US5662671A (en) * 1996-07-17 1997-09-02 Embol-X, Inc. Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries

Also Published As

Publication number Publication date
ATE208505T1 (de) 2001-11-15
PT912901E (pt) 2002-04-29
DE69708102D1 (de) 2001-12-13
AU2997597A (en) 1997-12-05
EP0912901A1 (en) 1999-05-06
EP0912901B1 (en) 2001-11-07
WO1997043650A1 (en) 1997-11-20
JP2000510700A (ja) 2000-08-22
DK0912901T3 (da) 2002-02-25
US6150114A (en) 2000-11-21
DE69708102T2 (de) 2002-07-11
CA2253402A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
ES2157220T3 (es) Aparato de ensayo analitico con control negativo y positivo incorporado.
ATE210295T1 (de) Verfahren und vorrichtung zur einschrittbestimmung von vollblut
ATE26487T1 (de) Einrichtung zur feststellung und zahlenmaessigen auswertung von agglutinaten.
DE69119750D1 (de) Messzelle für chemische oder biochemische proben
ATE207542T1 (de) Testvorrichtung mit einem stabilen kopplungsfarbstoff zur bestimmung von analyten
SE7902734L (sv) Forfarande och apparat for analys av blod
ATE278805T1 (de) Verfahren zur quantifizierung von cholesterol in lipoproteinen und quantifizierungsreagenzien
IT8019675A0 (it) Procedimento per rivelare ligandi in campioni di prova e relativo reagente analitico.
ES513992A0 (es) "un metodo para detectar sangre humana oculta en muestras de deposicion humana".
DK0901634T3 (da) System til bestemmelse af mindst en parameter i mindst en prøve af en fysiologisk væske samt en kassette
ATE146218T1 (de) Hemmung von padgem-vermittelter zellbindung
IT8124138A0 (it) Procedimento e apparecchio per determinare quantitativamente il livello di emoglobina in campioni biologici.
ES2132272T3 (es) Procedimiento para la determinacion de aductos de hemoglobina.
ES2166996T3 (es) Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios.
DK230981A (da) Fremgangsmaade og integralt analytisk legeme til bestemmelse af koncentrationen af en specifik ionisk analyt i en flydende proeve
DE59812075D1 (de) Verwendung von Annexinen als Lupus Antikoagulans Kontrolle oder Standard in Gerinnungstesten
NO903748L (no) Fremgangsmaate ved enzymatisk bestemmelse av analyttkonsentrasjoner.
DK173884A (da) Fremgangsmaade til kvantitativ bestemmelse af haemoglobinkoncentrationen i en biologisk proeve
PT878715E (pt) Composicao reagente de hemoglobina contendo cianeto e metodo proporcionando precisao exactidao aceitaveis e liberdade em relacao a interferencia de globulos brancos em analisadores automaticos de hematologia
SE7905852L (sv) Forfarande for bestemning av kreatinkinas
ES504126A0 (es) Un metodo analitico para la determinacion de uno o mas para-metros en muestras de pruebas
Lauwerys et al. Biological monitoring of toxic chemicals: The present position and perspectives of development.
DE68920876D1 (de) Kolorimetrische bestimmung von 2-bromo-2-nitro-1,3-propandiol oder seinen derivaten.
ES2047484T3 (es) Un metodo para determinar cuantitativamente el 3-oxo-5-beta-esteroide y reactivo para el mismo.
ES2111005T3 (es) Metodo para la determinacion de calcio total empleando un diluyente.